¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"factor VIII antibody"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antibody-mediated hypersensitivity
Ç×ü¸Å°³°ú¹Î¼º
antibody-mediated immunity
Ç×ü¸Å°³¸é¿ª
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
anticardiolipin antibody
Ç×Ä«µð¿À¸®ÇÉÇ×ü
anti-double stranded deoxyribonucleic acid antibody
Ç×ÀÌÁß°¡´ÚDNAÇ×ü
anti-dsDNA antibody
Ç×ÀÌÁß°¡´ÚDNAÇ×ü
antigen-antibody complex
Ç׿øÇ×üº¹ÇÕü
antigen-antibody interaction
Ç׿øÇ×ü»óÈ£ÀÛ¿ë
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
anti-idiotype antibody
Ç×À̵ð¿ÀŸÀÔÇ×ü, Ç×°³º°Æ¯ÀÌÇüÇ×ü
antimitochondrial antibody
Ç×¹ÌÅäÄܵ帮¾ÆÇ×ü, Ç׻縳üÇ×ü
antineutrophil cytoplasmic antibody
Ç×Áß¼º±¸¼¼Æ÷ÁúÇ×ü
antinuclear antibody
Ç×ÇÙÇ×ü
antinuclear antibody test
Ç×ÇÙÇ×ü°Ë»ç
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antibody synthesis
Ç×üÇÕ¼º
antibody titer
Ç×ü°¡
antibody screening test
Ç×ü¼±º°°Ë»ç
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
coagulation V factor
Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
exclusion of confounding factor
±³¶õº¯¼ö¹èÁ¦
growth factor
¼ºÀåÀÎÀÚ
intrinsic factor
³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antibody feedback mechanism
Ç×üµÇ¸ÔÀÓ±âÀü
antibody identification test
Ç×üȮÀΰ˻ç
antibody screening test
Ç×ü¼±º°°Ë»ç
antibody-binding site
Ç×ü°áÇÕºÎÀ§
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-mediated hypersensitivity
Ç×ü¸Å°³°ú¹Î
antibody-mediated immunity
Ç×ü¸Å°³¸é¿ª
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-antibody complex
Ç׿øÇ×üº¹ÇÕü
antigen-antibody interaction
Ç׿øÇ×ü¹ÝÀÀ
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
antinuclear antibody test
Ç×ÇÙÇ×ü°Ë»ç
atypical antibody
ÀÌÇüÇ×ü
autoimmune antibody
ÀÚ°¡¸é¿ªÇ×ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
EDRF=£¾endothelium derived relaxing factor
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ.
F factor
FÀÎÀÚ
Factor IX
IX ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor V
V ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor VII
VII ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor X activated
Ȱ¼ºÈ(üÀàõûù)µÈ X ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor XI
XI ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor XII
XII ÀÀ°íÀÎÀÚ(ëêͳì×í)
Fibrin-stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ(¡äÌïÒì×í)
Fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷(àéë«Ù½á¬øà)¼ºÀå¿äÀÎ(à÷íþé©ì×)
G-CSF (Granulocyte colony-stimulating factor)
°ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í)
GH releasing factor
¼ºÀå(à÷íþ)È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í).
GH releasing factor
¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ.
Growth factor
¼ºÀåÀÎÀÚ(à÷íþì×í)
Hageman factor
ÇϰԸ¸ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
anaphylactic antibody
¾Æ³ªÇʶô½Ã½º [À¯¹ß]Ç×ü
anti-La antibody
Ç×LaÇ×ü
anti-RNP antibody
Ç× RNPÇ×ü
anti-Ro antibody
Ç× RoÇ×ü
anti-SM antibody
Ç×SMÇ×ü
anti-cardiolipin antibody
Ç×Ä«µð¿À¸®ÇÉÇ×ü
anti-idiotype antibody
Ç×À̵ð¿ÀŸÀÔÇ×ü, Ç×°³º°Æ¯ÀÌÇüÇ×ü
anti-sm antibody
Ç×Sm Ç×ü(ù÷¡ù÷ô÷)
antibody
Ç×ü(ù÷ô÷)
antibody
Ç×ü(ù÷ô÷)
antibody
Ç×ü
antibody absorption
Ç×üÈíÂø
antibody absorption test
Ç×üÈí¼ö½ÃÇè(ù÷ô÷ýåâ¥ãËúÐ).
antibody binding site
Ç×ü°áÇÕºÎÀ§
antibody combining site
Ç×ü°áÇÕºÎ(ù÷ô÷Ì¿ùêÝ»).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½